Sponsor:
Janssen Research & Development, LLC
Code:
NCT04811560
Conditions
Acute Leukemias
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Bleximenib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations